IgE predicts future nonfatal myocardial infarction in men

Journal of Clinical Epidemiology

Volumn 49, Issue 2, 1996, Pages 203-209

  Langer, Robert D ^a,b   Criqui, Michael H ^a   Feigelson, Heather S ^a   McCann, Theresa J ^a   Hamburger, Robert N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Allergy; Cardiovascular disease; Coronary heart disease; IgE; Smoking

Indexed keywords

IMMUNOGLOBULIN E;

ADULT; AGED; ALLERGY; ARTERY MUSCLE; ARTICLE; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; FEMALE; HEART INFARCTION; HUMAN; HUMAN EXPERIMENT; ISCHEMIC HEART DISEASE; MALE; MEDIATOR; MORTALITY; NORMAL HUMAN; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; SMOKING; STROKE; THROMBOCYTE;

EID: 0029923365     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-4356(95)00548-X     Document Type: Article

References (35)

1. Rosenman RH, Bland RJ, Jenkins CD, et al. Coronary heart disease in the Western Collaborative Group Study. Final follow-up experience of 8 1/2 years. JAMA 1975; 233: 872-877.
2. Knauer KA, Lichtenstein LM, Adkinson NF, et al. Platelet activation during antigen-induced airway reactions in asthmatic subjects. N Engl J Med 1981; 304: 1404-1407.
3. Joseph M, Thorel T, Tsicopoulos A, et al. Nedocromil sodium inhibition of IgE-mediated activation of human mononuclear phagocytes and platelets from asthmatics. Drugs 1989; 37(1): 32-36.
4. Tsicopoulos A, Tonnel AB, Wallaert B, et al. A circulating suppressive factor of platelet cytotoxic functions after rush immunotherapy in hymenoptera venom hypersensitivity. J Immunol 1989; 142(8): 2683-2688.
5. Gresele P, Todisco T, Merante F, et al. Platelet activation and allergic asthma (letter). N Engl J Med 1982; 306: 549.
6. Morley J, Sanjar S, Page CP. The platelet in asthma. Lancet 1984; 2: 1142-1144.
7. Shimokawa H, Tomblike H, Nabeyama S, et al. Coronary artery spasm induced in atherosclerotic miniature swine. Science 1983; 221: 560-562.
8. Kalsner S, Richards R. Coronary arteries of cardiac patients are hyperactive and contain stores of amines: a mechanism for coronary spasm. Science 1984; 223: 1435-1437.
9. Ginsburg R, Bristow MR, Davis K, et al. Quantitative pharmacological responses of normal and atherosclerotic isolated human epicardial coronary arteries. Circulation 1984; 69: 430-440.
10. Ginsburg R, Bristow MR, Kantrowitz N, et al. Histamine provocation of clinical coronary artery spasm: implications concerning pathogenesis of variant angina pectoris. Am Heart J 1981; 102: 819-822.
11. Forman MB, Oates JA, Robertson D, et al. Increased adventitial mast cells in a patient with coronary spasm. N Engl J Med 1985; 313: 1138-1141.
12. Criqui MH, Seibles J, Hamburger RN, et al. Epidemiology of immunoglobulin E levels in a defined population. Ann Allergy 1990; 64: 308-313.
13. Criqui MH, Lee ER, Hamburger RN, et al. IgE and cardiovascular disease results from a population-based study. Am J Med 1987; 82: 964-968.
14. Gerrard JW, Heiner DC, Ko CG, et al. Immunoglobulin levels in smokers and nonsmokers. Ann Allergy 1980; 44: 261-262.
15. Burrows B, Halonen M, Barbee RA, et al. The relationship of serum immunoglobulin E to cigarette smoking. Am Rev Respir Dis 1981; 124: 523-525.
16. Zetterstrom O, Osterman K, Machado L, et al. Another smoking hazard: raised serum IgE concentration and increased risk of occupational allergy. Br Med J (Clin Res) 1981; 283: 1215-1217.
17. Burrows B, Halonen M, Lebowitz MD, et al. The relationship of serum immunoglobulin E, allergy, skin tests, and smoking to respiratory disorders. J Allergy Clin Immunol 1982; 70: 199-204.
18. Warren CP, Holford-Strevens V, Wong C, et al. The relationship between smoking and total immunoglobulin E levels. J Allergy Clin Immunol 1982; 68: 370-375.
19. Hallgren R, Nou E, Arrendale H, et al. Smoking and circulating IgE in bronchial carcinoma. Acta Med Scand 1982; 211: 269-273.
20. Bahna SC, Heiner DC, Myhre BA. Immunoglobulin E pattern in cigarette smokers. Allergy 1983; 38: 57-64.
21. Taylor RG, Gross E, Joyce H, et al. Smoking, allergy, and the differential white blood cell count. Thorax 1985; 40: 17-22.
22. Venables KM, Topping MD, Howe W, et al. Interaction of smoking and atopy in producing specific IgE antibody against a hapten protein conjugate. Br Med J 1985; 290: 201-204.
23. Bloom JW, Halonen M, Dunn AM, et al. Pneumococcus-specific immunoglobulin E in cigarette smokers. Clin Allergy 1986; 16: 25-32.
24. Szczeklik A, Sladek K, Szczerba A, et al. Serum immunoglobulin E response to myocardial infarction. Circulation 1988; 77: 1245-1249.
25. Ceska M, Lundkvist U. A new and simple radioimmunoassay method for the determination of IgE. Immunochemistry 1972; 9: 1021-1030.
26. Lipid Research Clinics Program. Manual of Laboratory Operations, vol. 1. Lipid and Lipoprotein Analysis. Bethesda, MD, National Heart, Lung, and Blood Institute. National Institutes of Health, 1974. (DHEW publication no. (NIH) 75-628.).
27. SPSS Inc. SPSS/PC+ for the IBM PC/XT/AT. Chicago, IL, 1986, Author.
28. Epicenter Software. Epilog Plus - Statistics package for epidemiology and clinical trials. Pasadena, CA, 1990, Author.
29. Maseri A. Coronary vasoconstriction: visible and invisible (editorial). N Engl J Med 1991; 325: 1578-1579.
30. Kaartinen M, Penttila A, Kovanen PT. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation 1994; 90: 1669-1678.
31. Barbash GI, White HD, Modan M, Diaz R, Hampton JR, Heikkila J, Kristinsson A, Moulopoulos S, Paolasso EAC, Van der Werf F, for the Investigators of the International tissue Plasminogen Activator/Streptokinase Mortality Trial. Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: experience gleaned from the international tissue plasminogen activator/streptokinase mortality trial. Circulation 1993; 87: 53-58.
32. McKenna WJ, Chew CYC, Oakley CM. Myocardial infarction with normal coronary angiogram: possible mechanism of smoking risk in coronary artery disease. Br Heart J 1980; 43: 493-498.
33. Cryer PE, Haymond MW, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 1976; 53: 354-355.
34. Cryer PE, Maouad J, Fernandez F, Barrillon A, Gerbaux A, Gay J. Diffuse or segmental narrowing (spasm) of the coronary arteries during smoking demonstrated on angiography. Am J Cardiol 1984; 53: 354-355.
35. Criqui MH. Serum immunoglobulin E after myocardial infarction (letter). Circulation 1988; 78: 1322.